Trials / Completed
CompletedNCT04483245
Platelet Activation by a Collagen Analogue in Hemorrhagic Situations
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 83 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Dijon University Hospital and the Dijon-based NVH Medicinal Company have developed a recombinant mini-collagen NVH020B with platelet and Willebrand factor binding activity. Its small size and granular, non-fibrillar presentation make it suitable for use as an injectable hemostat in patients with a hemorrhage or other emergency under antiplatelet therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sampling | Blood sampling |
Timeline
- Start date
- 2021-12-07
- Primary completion
- 2023-04-11
- Completion
- 2023-04-11
- First posted
- 2020-07-23
- Last updated
- 2023-07-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04483245. Inclusion in this directory is not an endorsement.